A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression | Nature Communications
Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes | Modern Pathology
Chondrosarcoma-from Molecular Pathology to Novel Therapies
Chondrosarcoma | SpringerLink
Chondrosarcoma-from Molecular Pathology to Novel Therapies
JCM | Free Full-Text | Outcomes and Complications of Pelvic Chondrosarcomas Treated Using Navigation Guidance and Multidisciplinary Approach: Is the Tumor Volume a Prognostic Factor?
Chondrosarcoma - Causes, Symptoms, Prognosis, Diagnosis, Treatment
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment - The Lancet Oncology
Chondrosarcoma of the spine—a case report | SpringerLink
Chondrosarcoma-from Molecular Pathology to Novel Therapies
PDF) The Clinical Approach Towards Chondrosarcoma
IJMS | Free Full-Text | Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment - The Lancet Oncology
Chondrosarcoma-from Molecular Pathology to Novel Therapies
PDF) The Clinical Approach Towards Chondrosarcoma
PDF) Response of conventional chondrosarcoma to gemcitabine alone: a case report
Effect of Cryoablation Treatment on the Protein Expression Profile of Low-Grade Central Chondrosarcoma Identified by LC-ESI-MS/MS | Journal of the American Society for Mass Spectrometry
Chondrosarcoma and Chondroma - Difference
PDF) Establishment and Characterization of a Continuous Human Chondrosarcoma Cell Line, Ch-2879: Comparative Histologic and Genetic Studies With Its Tumor of Origin | Samuel Navarro and José López-guerrero - Academia.edu
PDF) The Clinical Approach Towards Chondrosarcoma
A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression | Nature Communications
